Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
NCT07171983

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Led by Bristol-Myers Squibb · Updated on 2026-05-07

46

Participants Needed

9

Research Sites

77 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis

CONDITIONS

Official Title

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants with Rheumatoid Arthritis must have onset after age 18.
  • Participants who meet 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for RA.
  • Participants must have evidence of swelling in at least 1 joint of the hand or wrist by clinical examination at screening and Day -1.
  • Participants must have been an incomplete responder to prior methotrexate (MTX) treatment.
Not Eligible

You will not qualify if you...

  • Participants must not have any significant medical condition, other than Rheumatoid Arthritis, that substantially increases risk in the Investigator's judgment.
  • Participants must not have any condition aside from RA that confounds the ability to interpret study data.
  • Participants must not have severe Rheumatoid Arthritis as assessed by Disease Activity Score 28 c-reactive protein (DAS28-CRP) at screening or Day -1.
  • Other protocol-defined Inclusion/Exclusion criteria apply.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Local Institution - 0006

Hyderabad, Andhra Pradesh, India, 500 082

Not Yet Recruiting

2

Local Institution - 0004

Ahmedabad, Gujarat, India, 382428

Not Yet Recruiting

3

Local Institution - 0003

Bangalore, Karnataka, India, 560 034

Not Yet Recruiting

4

Local Institution - 0009

Mysuru, Karnataka, India, 5700004

Not Yet Recruiting

5

All India Institute of Medical Sciences (AIIMS) - Nagpur

Nagpur, Maharashtra, India, 441108

Actively Recruiting

6

Life Point Mutispecialty Hospital Pvt. Ltd.

Pune, Maharashtra, India, 411057

Actively Recruiting

7

Kalinga Institute of Medical Sciences- Bhubaneswar

Bhubaneswar, Odisha, India, 751024

Actively Recruiting

8

Local Institution - 0002

Hyderabad, Telangana, India, 500004

Not Yet Recruiting

9

Krishna Institute of Medical Sciences Limited

Secunderabad, Telangana, India, 500003

Actively Recruiting

Loading map...

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

F

First line of the email MUST contain NCT # and Site #.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis | DecenTrialz